About 97,200 results
Open links in new tab
  1. Blood | American Society of Hematology

    5 days ago · In this week's episode, Blood editor Dr. James Griffin interviews authors Drs. Vincent Muczynski and Mark Geyer on their latest research published in Blood. Dr. Muczynski's …

  2. 2024 Most Read Articles | Blood | American Society of Hematology

    Blood is pleased to announce the following most read articles that were published in 2024. Management of ALL in adults: 2024 ELN recommendations from a European expert panel

  3. Volume 146 Issue 26 | Blood | American Society of Hematology

    5 days ago · In this Blood Spotlight, Jaworek and Bröckelmann summarize what is known about these immune-related toxicities, emphasizing those which may persist, become chronic, or …

  4. Blood Global Hematology | American Society of Hematology

    Blood Global Hematology is an open-access, peer-reviewed journal that aims to publish high-quality research, local adaptions of clinical guidelines, epidemiology and public health …

  5. Safety and efficacy of standard-of-care ciltacabtagene autoleucel …

    Jan 2, 2025 · Response was assessed by treating investigators based on the International Myeloma Working Group criteria 13 (see the supplemental Methods, available on the Blood …

  6. Venetoclax-obinutuzumab for previously untreated chronic …

    Oct 31, 2024 · The study protocol is included in the supplemental Information, available on the Blood website. Follow-up is ongoing, all patients are off study treatment.

  7. Current myeloproliferative neoplasm scoring systems for clinical ...

    Jan 16, 2025 · Hélène Pasquer, Jean-Jacques Kiladjian, Lina Benajiba; Current myeloproliferative neoplasm scoring systems for clinical practice. Blood 2025; 145 (3): 257–276. doi: …

  8. Manuscript Preparation | Blood | American Society of Hematology

    Questions raised by Blood staff will be referred to the Editors, who may then request the original data from the author (s) for comparison with the submitted figures. Such manuscripts will be …

  9. Epcoritamab plus GemOx in transplant-ineligible …

    Apr 10, 2025 · From 25 January 2021 to 15 December 2023, 103 patients with ASCT-ineligible R/R DLBCL were treated with epcoritamab plus GemOx (supplemental Figure 1, available on …

  10. Sickle cell trait does not cause “sickle cell crisis” leading to ...

    Mar 27, 2025 · Dear Editors, This correspondence addresses significant epistemological, methodological, and medico-legal concerns regarding the article by Weeks et al., entitled …